newsfilter
← Latest News
GlobeNewswire·

Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom

Lyon (France), February 13, 2026 – Valneva SE (NASDAQ:VALN, PARIS:VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company's single‑dose chikungunya vaccine,